Abound Wealth Management’s Organon & Co OGN Stock Holding History

Abound Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$417	Sell	31 -2	-6%	-$24	﹤0.01%	976
2026 Q1	$197	Hold	33	–	–	﹤0.01%	1244
2025 Q4	$235	Hold	33	–	–	﹤0.01%	1125
2025 Q3	$350	Hold	33	–	–	﹤0.01%	976
2025 Q2	$318	Hold	33	–	–	﹤0.01%	912
2025 Q1	$488	Sell	33 -6	-15%	-$92	﹤0.01%	820
2024 Q4	$579	Hold	39	–	–	﹤0.01%	783
2024 Q3	$742	Sell	39 -11	-22%	-$228	﹤0.01%	806
2024 Q2	$1.03K	Sell	50 -4	-7%	-$79	﹤0.01%	722
2024 Q1	$1.01K	Buy	54 +4	+8%	+$69	﹤0.01%	775
2023 Q4	$718	Sell	50 -38	-43%	-$517	﹤0.01%	838
2023 Q3	$1.53K	Sell	88 -8	-8%	-$167	﹤0.01%	656
2023 Q2	$2K	Sell	96 -3	-3%	-$65	﹤0.01%	646
2023 Q1	$2.33K	Buy	99 +3	+3%	+$81	﹤0.01%	569
2022 Q4	$2.67K	Buy	96 +23	+32%	+$588	﹤0.01%	489
2022 Q3	$1.7K	Buy	+73	New	+$2.2K	﹤0.01%	514

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Abound Wealth Management's OGN Position: Q2 2026 in Review

Abound Wealth Management reduced its Organon & Co (OGN) stake by 6.1% in Q2 2026, selling an estimated $24 and leaving 31 shares worth $417. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Abound Wealth Management first reported a position in OGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $2.67K in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Abound Wealth Management held 31 shares of Organon & Co worth $417 as of Q2 2026.
Abound Wealth Management sold 2 Organon & Co shares in Q2 2026, an estimated $24.
Organon & Co made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #976 holding.
Abound Wealth Management first reported a position in Organon & Co in Q3 2022 and has held it in 16 quarters since.
Abound Wealth Management's Organon & Co position peaked at $2.67K in Q4 2022.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.